May 10, 2026
Safety recommendations for two medicinal products: the CAR-T cell therapy axicabtagene ciloleucel (Yescarta) and the tyrosine kinase inhibitor ponatinib (Iclusig).
Safety recommendations for two medicinal products: the CAR-T cell therapy axicabtagene ciloleucel (Yescarta) and the tyrosine kinase inhibitor ponatinib (Iclusig).
World Hand Hygiene Day, observed annually on 5 May, has for 18 years championed the single most effective measure to prevent healthcare-associated infections (HAIs): timely and proper hand hygiene.
Regulatory safety information on medicinal products from national pharmacovigilance centres worldwide and the WHO Advisory Committee on Safety of Medicinal Products (ACSoMP).
Based on the WHO Guidelines for Malaria (August 2025) and Supporting Global Evidence
Medical overview of the history, types, and adverse effects of RPT, with a special focus on real-world pharmacovigilance data.
Comprehensive analysis of the MedDRA Version 29.0 IME list, including newly added terms, demoted terms, primary SOC changes, and the clinical significance of key updates. A comparative analysis with Version 28.1 highlights the evolution of this essential regulatory tool.
ATMPs are dynamic, often patient‑specific, and designed to achieve durable or even curative effects through permanent genetic modification, cellular engraftment, or tissue regeneration.
Advancing Medication Safety Through Knowledge and Vigilance
